Compare PRVA & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRVA | NVST |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | 1226 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.8B |
| IPO Year | 2021 | 2019 |
| Metric | PRVA | NVST |
|---|---|---|
| Price | $19.74 | $23.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $31.17 | $26.46 |
| AVG Volume (30 Days) | 1.1M | ★ 2.6M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.64 | ★ 104.31 |
| EPS | 0.09 | ★ 0.56 |
| Revenue | $2,122,842,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | $18.19 | $6.67 |
| Revenue Next Year | $10.72 | $3.55 |
| P/E Ratio | $215.44 | ★ $42.98 |
| Revenue Growth | ★ 22.26 | N/A |
| 52 Week Low | $18.92 | $18.77 |
| 52 Week High | $28.82 | $30.42 |
| Indicator | PRVA | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 37.49 | 35.83 |
| Support Level | $19.62 | $22.31 |
| Resistance Level | $24.14 | $28.51 |
| Average True Range (ATR) | 0.60 | 0.78 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 34.99 | 21.67 |
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.